Crossref
Development and Validation of HPLC-UV Method for Determination of Meloxicam in Tablet Dosage Formulation
Pharmata · 28.07.2023 · 3 (3) · 59-63
DOI: 10.5152/pharmata.2023.23008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmata, online erschienen am 28.07.2023. Verfasst von Reyhan Sila CELIK und 2 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
CELIK, R. S., BAYRAK, B., & KADIOGLU, Y. (2023). Development and Validation of HPLC-UV Method for Determination of Meloxicam in Tablet Dosage Formulation. Pharmata, 3(3), 59-63. https://doi.org/10.5152/pharmata.2023.23008
Vancouver
CELIK RS, BAYRAK B, KADIOGLU Y. Development and Validation of HPLC-UV Method for Determination of Meloxicam in Tablet Dosage Formulation. Pharmata. 2023;3(3):59-63. doi:10.5152/pharmata.2023.23008
BibTeX
@article{CELIK2023,
author = {CELIK, Reyhan Sila and BAYRAK, Burak and KADIOGLU, Yucel},
title = {Development and Validation of HPLC-UV Method for Determination of Meloxicam in Tablet Dosage Formulation},
journal = {Pharmata},
year = {2023},
volume = {3},
number = {3},
pages = {59--63},
doi = {10.5152/pharmata.2023.23008}
}
EUVIMED